A Randomized Phase 2 Trial of 177Lu Radiolabeled Anti-PSMA Monoclonal Antibody J591in Patients with High-Risk Castrate, Biochemically Relapsed Prostate Cancer

Abstract

Clinical trial has received WCMC IRB and CTSC approval with enrollment of initial 5 subjects at WCMC. An additional 18 subjects enrolled (15 treated) at participating sub-sites. Reports submitted to WCMC DSMB with recommendation to proceed with enrollment.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Sep 01, 2012
Accession Number
ADA566933

Entities

People

  • Scott T Tagawa

Organizations

  • Cornell University

Tags

DTIC Thesaurus Topics

  • Clinical Trials
  • Department Of Defense
  • Electronic Mail
  • Health Services
  • Institutional Review Board
  • Medical Personnel
  • Neoplasms
  • New York
  • Oncology
  • Physical Properties
  • Prostate Cancer
  • Radiation Oncology
  • Radiotherapy
  • Therapy

Readers

  • Clinical Trial Research.
  • Oncology (Cancer Research).